{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:43:59Z","timestamp":1794566639927,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obesity is accompanied by hormonal, inflammatory and endothelial alterations. These alterations induce a stimulation of several other mechanisms that contribute to the hypertensive state and to increase the cardiovascular morbidity. This pilot, open\u2009-\u2009label, single-\u2009center, prospective clinical trial aimed to evaluate the effect of very low-\u2009calorie ketogenic diet (VLCKD) on blood pressure (BP) in women with of obesity and hypertension.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 137 women, who met the inclusion criteria and accepted to adhere to VLCKD, were consecutively enrolled. Assessment of anthropometric parameters (weight, height, and waist circumference), body composition (through bioelectrical impedance analysis), systolic (SBP) and diastolic blood pressure (DBP) and blood sample collection were carried out at baseline and after 45\u2009days of the active phase of VLCKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After VLCKD all the women experienced a significant reduction in body weight and an overall improvement of body composition parameters. In addition, high sensitivity C reactive protein (hs-\u2009CRP) levels were significantly diminished (p\u2009&lt;\u20090.001), while phase angle (PhA) increased by almost 9% (p\u2009&lt;\u20090.001). Interestingly, both SBP and DBP were significantly improved (-12.89% and \u2212\u200910.77%, respectively; p\u2009&lt;\u20090.001). At baseline, SBP and DBP showed statistically significant correlations with body mass index (BMI), waist circumference, hs-CRP levels, PhA, total body water (TBW), extracellular water (ECW), Na\u2009\/\u2009K ratio, and fat mass. Even after VLCKD, all correlations among SBP and DBP with the study variables were statistically significant, except for the association between DBP and Na\u2009\/\u2009K ratio. Changes (%) in both SBP and DBP were associated with \u2206BMI%, \u2206PhA% and \u2206hs-\u2009CRP levels (p\u2009&lt;\u20090.001). In addition, only \u2206SBP% was associated with \u2206waist circumference (p\u2009=\u20090.017), \u2206TBW (p\u2009=\u20090.017), and \u2206fat mass (p\u2009&lt;\u20090.001); while only \u2206DBP% was associated with \u2206ECW (p\u2009=\u20090.018), and \u2206Na\u2009\/\u2009K ratio (p\u2009=\u20090.048). After adjusting for \u2206BMI, \u2206WC, \u2206PhA, \u2206TBW, and \u2206fat mass, the correlation between changes in \u2206SBP and \u2206hs\u2009-CRP levels remained statistically significant (p\u2009&lt;\u20090.001). Similarly, the correlation between \u2206DBP and \u2206hs-\u2009CRP levels also remained statistically significant after adjustment for \u2206BMI, \u2206PhA, \u2206Na\u2009\/\u2009K ratio, and \u2206ECW (p\u2009&lt;\u20090.001). From multiple regression analysis \u2206hs-\u2009CRP levels seemed to be the main predictor of changes of BP (p\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>VLCKD reduces BP in women with of obesity and hypertension in a safely manner.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-03956-4","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T10:03:09Z","timestamp":1676628189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Very low-calorie ketogenic diet (VLCKD): an antihypertensive nutritional approach"],"prefix":"10.1186","volume":"21","author":[{"given":"Luigi","family":"Barrea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Santangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Luc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Docimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Muscogiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"3956_CR1","unstructured":"WHO. Cardiovascular diseases\u2014fact sheets https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"issue":"21","key":"3956_CR2","first-page":"e984","volume":"143","author":"TM Powell\u2009-\u2009Wiley","year":"2021","unstructured":"Powell\u2009-\u2009Wiley TM, Poirier P, Burke LE, Despres JP, Gordon\u2009-\u2009Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984\u20131010.","journal-title":"Circulation"},{"issue":"2","key":"3956_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","volume":"75","author":"FD Fuchs","year":"2020","unstructured":"Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285\u201392.","journal-title":"Hypertension"},{"issue":"6","key":"3956_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity\u2009-\u2009induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116(6):991\u20131006.","journal-title":"Circ Res"},{"issue":"5","key":"3956_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/hr.2015.145","volume":"39","author":"P Krzesinski","year":"2016","unstructured":"Krzesinski P, Stanczyk A, Piotrowicz K, Gielerak G, Uzieblo\u2009-\u2009Zyczkowska B, Skrobowski A. Abdominal obesity and hypertension: a double burden to the heart. Hypertens Res. 2016;39(5):349\u201355.","journal-title":"Hypertens Res"},{"issue":"5","key":"3956_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/obr.12656","volume":"19","author":"A Jayedi","year":"2018","unstructured":"Jayedi A, Rashidy\u2009-\u2009Pour A, Khorshidi M, Shab\u2009-\u2009Bidar S. Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose\u2009-\u2009response meta\u2009-\u2009analysis of more than 2.3 million participants. Obes Rev. 2018;19(5):654\u201367.","journal-title":"Obes Rev"},{"issue":"4","key":"3956_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1161\/HYPERTENSIONAHA.109.135178","volume":"54","author":"L Aucott","year":"2009","unstructured":"Aucott L, Rothnie H, McIntyre L, Thapa M, Waweru C, Gray D. Long\u2009-\u2009term weight loss from lifestyle intervention benefits blood pressure?: a systematic review. Hypertension. 2009;54(4):756\u201362.","journal-title":"Hypertension"},{"issue":"5","key":"3956_CR8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","volume":"42","author":"JE Neter","year":"2003","unstructured":"Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta\u2009-\u2009analysis of randomized controlled trials. Hypertension. 2003;42(5):878\u201384.","journal-title":"Hypertension"},{"issue":"3","key":"3956_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1001\/jama.2017.20813","volume":"319","author":"S Ikramuddin","year":"2018","unstructured":"Ikramuddin S, Korner J, Lee WJ, Thomas AJ, Connett JE, Bantle JP, et al. Lifestyle intervention and Medical Management with vs without Roux\u2009-\u2009en-Y gastric bypass and control of Hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5\u2009years in the diabetes surgery study. JAMA. 2018;319(3):266\u201378.","journal-title":"JAMA"},{"issue":"11","key":"3956_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s11883-022-01062-2","volume":"24","author":"MR Pedrosa","year":"2022","unstructured":"Pedrosa MR, Franco DR, Gieremek HW, Vidal CM, Bronzeri F, de Cassia Rocha A, et al. GLP\u2009-\u20091 agonist to treat obesity and prevent Cardiovascular Disease: what have we achieved so far? Curr Atheroscler Rep. 2022;24(11):867\u201384.","journal-title":"Curr Atheroscler Rep"},{"key":"3956_CR11","unstructured":"Administration USFaD. FDA approves weight management drug for patients aged 12 and older. https:\/\/www.fda.gov\u2009\/\u2009drugs\/news\u2009-\u2009events-human\u2009-\u2009drugs\/fda\u2009-\u2009approves-weight\u2009-\u2009management-drug\u2009-\u2009patients-aged\u2009-\u200912-and\u2009-\u2009older#:~:text\u2009=\u2009The%20U.S.%20Food\u2009%\u200920and\u2009%\u200920Drug\u2009%\u200920Administration\u2009%\u200920has\u2009%\u200920approved,who\u2009%\u200920weigh\u2009%\u200920more\u2009%\u200920than\u2009%\u20092060%20\u2009kg\u2009%\u200920%28132\u2009%\u200920pounds\u2009%\u200929."},{"issue":"2","key":"3956_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/03007995.2016.1251892","volume":"33","author":"H Bays","year":"2017","unstructured":"Bays H, Pi\u2009-\u2009Sunyer X, Hemmingsson JU, Claudius B, Jensen CB, Van Gaal L. Liraglutide 3.0\u2009mg for weight management: weight\u2009-\u2009loss dependent and independent effects. Curr Med Res Opin. 2017;33(2):225\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"3956_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown\u2009-\u2009Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"},{"issue":"2","key":"3956_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11906-019-0915-1","volume":"21","author":"JB Cohen","year":"2019","unstructured":"Cohen JB, Gadde KM. Weight loss medications in the treatment of obesity and hypertension. Curr Hypertens Rep. 2019;21(2):16.","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"3956_CR15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jama.2016.1558","volume":"315","author":"SE Nissen","year":"2016","unstructured":"Nissen SE, Wolski KE, Prcela L, Wadden T, Buse JB, Bakris G, et al. Effect of naltrexone\u2009-\u2009bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: a Randomized Clinical Trial. JAMA. 2016;315(10):990\u20131004.","journal-title":"JAMA"},{"issue":"2","key":"3956_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000515381","volume":"14","author":"G Muscogiuri","year":"2021","unstructured":"Muscogiuri G, El Ghoch M, Colao A, Hassapidou M, Yumuk V, Busetto L, et al. European guidelines for obesity management in adults with a very low\u2009-\u2009calorie ketogenic Diet: a systematic review and Meta\u2009-\u2009analysis. Obes Facts. 2021;14(2):222\u201345.","journal-title":"Obes Facts"},{"issue":"6","key":"3956_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ehjcvp\/pvz050","volume":"6","author":"C Byrne","year":"2020","unstructured":"Byrne C, Pareek M, Vaduganathan M, Biering\u2009-\u2009Sorensen T, Qamar A, Pandey A, et al. Intensive blood pressure lowering in different age categories: insights from the systolic blood pressure intervention trial. Eur Heart J Cardiovasc Pharmacother. 2020;6(6):356\u201363.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"3956_CR18","unstructured":"(WHO) WHO. A healthy lifestyle\u2014WHO recommendations."},{"key":"3956_CR19","unstructured":"Statistics NCfH. Anthropometry Procedures Manual. [Available from: https:\/\/www.cdc.gov\u2009\/\u2009nchs\/data\u2009\/\u2009nhanes\/nhanes_11_12\u2009\/\u2009Anthropometry_Procedures_Manual.pdf."},{"issue":"6","key":"3956_CR20","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.clnu.2004.09.012","volume":"23","author":"UG Kyle","year":"2004","unstructured":"Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gomez J, et al. Bioelectrical impedance analysis\u2009-\u2009part II: utilization in clinical practice. Clin Nutr. 2004;23(6):1430\u201353.","journal-title":"Clin Nutr"},{"issue":"3","key":"3956_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"TA Pearson","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499\u2013511.","journal-title":"Circulation"},{"issue":"2","key":"3956_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/nu11020338","volume":"11","author":"L Chiavaroli","year":"2019","unstructured":"Chiavaroli L, Viguiliouk E, Nishi SK, Blanco Mejia S, Rahelic D, Kahleova H, et al. DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta\u2014analyses. Nutrients. 2019;11(2):338.","journal-title":"Nutrients."},{"issue":"11","key":"3956_CR23","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/nu10111700","volume":"10","author":"G De Pergola","year":"2018","unstructured":"De Pergola G, D\u2019Alessandro A. Influence of Mediterranean diet on blood pressure. Nutrients. 2018;10(11):1700.","journal-title":"Nutrients."},{"key":"3956_CR24","doi-asserted-by":"publisher","first-page":"m696","DOI":"10.1136\/bmj.m696","volume":"369","author":"L Ge","year":"2020","unstructured":"Ge L, Sadeghirad B, Ball GDC, da Costa BR, Hitchcock CL, Svendrovski A, et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta\u2009-\u2009analysis of randomised trials. BMJ. 2020;369:m696.","journal-title":"BMJ"},{"key":"3956_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1741-7015-11-207","volume":"11","author":"E Toledo","year":"2013","unstructured":"Toledo E, Hu FB, Estruch R, Buil\u2009-\u2009Cosiales P, Corella D, Salas\u2009-\u2009Salvado J, et al. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC Med. 2013;11:207.","journal-title":"BMC Med"},{"issue":"5","key":"3956_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cjca.2020.01.013","volume":"36","author":"L Xiao","year":"2020","unstructured":"Xiao L, Harrison DG. Inflammation in hypertension. Can J Cardiol. 2020;36(5):635\u201347.","journal-title":"Can J Cardiol"},{"issue":"2","key":"3956_CR27","first-page":"158","volume":"49","author":"A Agita","year":"2017","unstructured":"Agita A, Alsagaff MT. Inflammation, immunity, and hypertension. Acta Med Indones. 2017;49(2):158\u201365.","journal-title":"Acta Med Indones"},{"issue":"7","key":"3956_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/jhh.2013.111","volume":"28","author":"FG Hage","year":"2014","unstructured":"Hage FG. C\u2009-\u2009reactive protein and hypertension. J Hum Hypertens. 2014;28(7):410\u20135.","journal-title":"J Hum Hypertens"},{"issue":"9","key":"3956_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1751-7176.2008.00002.x","volume":"10","author":"E Magen","year":"2008","unstructured":"Magen E, Mishal J, Paskin J, Glick Z, Yosefy C, Kidon M, et al. Resistant arterial hypertension is associated with higher blood levels of complement C3 and C\u2009-\u2009reactive protein. J Clin Hypertens (Greenwich). 2008;10(9):677\u201383.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"3956_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/jhh.2010.125","volume":"26","author":"BM Cheung","year":"2012","unstructured":"Cheung BM, Ong KL, Tso AW, Leung RY, Xu A, Cherny SS, et al. C\u2009-\u2009reactive protein as a predictor of hypertension in the Hong Kong Cardiovascular risk factor prevalence study (CRISPS) cohort. J Hum Hypertens. 2012;26(2):108\u201316.","journal-title":"J Hum Hypertens"},{"issue":"5","key":"3956_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/ajh\/hps095","volume":"26","author":"SY Chuang","year":"2013","unstructured":"Chuang SY, Hsu PF, Chang HY, Bai CH, Yeh WT, Pan HW. C\u2009-\u2009reactive protein predicts systolic blood pressure and pulse pressure but not diastolic blood pressure: the Cardiovascular Disease Risk factors Two\u2009-\u2009Township Study. Am J Hypertens. 2013;26(5):657\u201364.","journal-title":"Am J Hypertens"},{"issue":"4","key":"3956_CR32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/HJH.0b013e328326f801","volume":"27","author":"V Dauphinot","year":"2009","unstructured":"Dauphinot V, Roche F, Kossovsky MP, Schott AM, Pichot V, Gaspoz JM, et al. C\u2009-\u2009reactive protein implications in new\u2009-\u2009onset hypertension in a healthy population initially aged 65\u2009years: the Proof study. J Hypertens. 2009;27(4):736\u201343.","journal-title":"J Hypertens"},{"issue":"2","key":"3956_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/jhh.2010.91","volume":"25","author":"SG Lakoski","year":"2011","unstructured":"Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, et al. The relationship between inflammation, obesity and risk for hypertension in the multi\u2009-\u2009ethnic study of atherosclerosis (MESA). J Hum Hypertens. 2011;25(2):73\u20139.","journal-title":"J Hum Hypertens"},{"issue":"22","key":"3956_CR34","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1001\/jama.290.22.2945","volume":"290","author":"HD Sesso","year":"2003","unstructured":"Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C\u2009-\u2009reactive protein and the risk of developing hypertension. JAMA. 2003;290(22):2945\u201351.","journal-title":"JAMA"},{"issue":"3","key":"3956_CR35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/01.HYP.0000256956.61872.aa","volume":"49","author":"TJ Wang","year":"2007","unstructured":"Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, Tofler GH, et al. Multiple biomarkers and the risk of incident hypertension. Hypertension. 2007;49(3):432\u20138.","journal-title":"Hypertension"},{"issue":"6","key":"3956_CR36","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.clnu.2012.05.008","volume":"31","author":"K Norman","year":"2012","unstructured":"Norman K, Stobaus N, Pirlich M, Bosy\u2009-\u2009Westphal A. Bioelectrical phase angle and impedance vector analysis\u2013clinical relevance and applicability of impedance parameters. Clin Nutr. 2012;31(6):854\u201361.","journal-title":"Clin Nutr"},{"issue":"8","key":"3956_CR37","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1017\/S0007114511004028","volume":"107","author":"N Stobaus","year":"2012","unstructured":"Stobaus N, Pirlich M, Valentini L, Schulzke JD, Norman K. Determinants of bioelectrical phase angle in disease. Br J Nutr. 2012;107(8):1217\u201320.","journal-title":"Br J Nutr"},{"issue":"1","key":"3956_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12967-021-02826-1","volume":"19","author":"L Barrea","year":"2021","unstructured":"Barrea L, Donnarumma M, Cacciapuoti S, Muscogiuri G, De Gregorio L, Blasio C, et al. Phase angle and Mediterranean diet in patients with acne: two easy tools for assessing the clinical severity of disease. J Transl Med. 2021;19(1):171.","journal-title":"J Transl Med"},{"issue":"1","key":"3956_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12967-016-0889-6","volume":"14","author":"L Barrea","year":"2016","unstructured":"Barrea L, Macchia PE, Di Somma C, Napolitano M, Balato A, Falco A, et al. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome. J Transl Med. 2016;14(1):130.","journal-title":"J Transl Med"},{"issue":"8","key":"3956_CR40","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/nu11081747","volume":"11","author":"L Barrea","year":"2019","unstructured":"Barrea L, Muscogiuri G, Laudisio D, Di Somma C, Salzano C, Pugliese G, et al. Phase angle: A possible biomarker to quantify inflammation in subjects with obesity and 25 (OH) D deficiency. Nutrients. 2019;11(8):1747.","journal-title":"Nutrients."},{"issue":"6","key":"3956_CR41","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/nu13061997","volume":"13","author":"L Barrea","year":"2021","unstructured":"Barrea L, Muscogiuri G, Pugliese G, de Alteriis G, Maisto M, Donnarumma M, et al. Association of trimethylamine N\u2014Oxide (TMAO) with the clinical severity of hidradenitis suppurativa (Acne Inversa). Nutrients. 2021;13(6):1997.","journal-title":"Nutrients."},{"issue":"9","key":"3956_CR42","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s41366-022-01152-w","volume":"46","author":"L Barrea","year":"2022","unstructured":"Barrea L, Muscogiuri G, Aprano S, Vetrani C, de Alteriis G, Varcamonti L, et al. Phase angle as an easy diagnostic tool for the nutritionist in the evaluation of inflammatory changes during the active stage of a very low\u2009-\u2009calorie ketogenic diet. Int J Obes (Lond). 2022;46(9):1591\u20137.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"3956_CR43","first-page":"1","volume":"73","author":"M Latka","year":"2016","unstructured":"Latka M, Wojtowicz K, Drozdz T, Dabrowska E, Kwinta P, Pietrzyk JA, et al. Relationship between water compartments, body composition assessed by bioelectrical impedance analysis and blood pressure in school children. Przegl Lek. 2016;73(1):1\u20135.","journal-title":"Przegl Lek"},{"issue":"1","key":"3956_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5527\/wjn.v7.i1.1","volume":"7","author":"ME Roumelioti","year":"2018","unstructured":"Roumelioti ME, Glew RH, Khitan ZJ, Rondon\u2009-\u2009Berrios H, Argyropoulos CP, Malhotra D, et al. Fluid balance concepts in medicine: principles and practice. World J Nephrol. 2018;7(1):1\u201328.","journal-title":"World J Nephrol"},{"issue":"4","key":"3956_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s10286-002-0055-5","volume":"12","author":"J Jordan","year":"2002","unstructured":"Jordan J. Acute effect of water on blood pressure. What do we know? Clin Auton Res. 2002;12(4):250\u20135.","journal-title":"Clin Auton Res"},{"issue":"4","key":"3956_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/08860220701260461","volume":"29","author":"W Chen","year":"2007","unstructured":"Chen W, Cheng LT, Wang T. Salt and fluid intake in the development of hypertension in peritoneal dialysis patients. Ren Fail. 2007;29(4):427\u201332.","journal-title":"Ren Fail"},{"issue":"8","key":"3956_CR47","first-page":"e27706","volume":"14","author":"AS Mohammedin","year":"2022","unstructured":"Mohammedin AS, AlSaid AH, Almalki AM, Alsaiari AR, Alghamdi FN, Jalalah AA, et al. Assessment of hydration status and blood pressure in a Tertiary Care Hospital at Al\u2009-\u2009Khobar. Cureus. 2022;14(8):e27706.","journal-title":"Cureus"},{"issue":"1","key":"3956_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000343412","volume":"36","author":"Y Ohashi","year":"2012","unstructured":"Ohashi Y, Otani T, Tai R, Okada T, Tanaka K, Tanaka Y, et al. Associations of proteinuria, fluid volume imbalance, and body mass index with circadian ambulatory blood pressure in chronic kidney disease patients. Kidney Blood Press Res. 2012;36(1):231\u201341.","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"3956_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40885-021-00192-0","volume":"28","author":"A Slabbert","year":"2022","unstructured":"Slabbert A, Chothia MY. The association between office blood pressure and fluid status using bioimpedance spectroscopy in stable continuous ambulatory peritoneal dialysis patients. Clin Hypertens. 2022;28(1):8.","journal-title":"Clin Hypertens"},{"issue":"2","key":"3956_CR50","first-page":"75","volume":"10","author":"R Cianci","year":"2006","unstructured":"Cianci R, Citro F, Migneco A, Baldoni F, Minisci MC, Di Daniele N, et al. Body fluid compartments in hypertension. Eur Rev Med Pharmacol Sci. 2006;10(2):75\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3956_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/5584_2016_49","volume":"956","author":"AS Vischer","year":"2017","unstructured":"Vischer AS, Burkard T. Principles of blood pressure measurement\u2014current techniques, Office vs ambulatory blood pressure measurement. Adv Exp Med Biol. 2017;956:85\u201396.","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"3956_CR52","doi-asserted-by":"publisher","first-page":"778","DOI":"10.7326\/M15-2223","volume":"163","author":"AL Siu","year":"2015","unstructured":"Siu AL, Force USPST. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778\u201386.","journal-title":"Ann Intern Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03956-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-03956-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03956-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T11:11:26Z","timestamp":1676632286000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03956-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3956"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-03956-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"assertion":[{"value":"13 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Local Ethical Committee (n. 50\u2009\/\u200920) and carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments that involved humans. The aim of the study was clearly explained to all the study participants and a written informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}